Relationships with people you know only superficially can help develop a sense of belonging and provide motivation to engage in activities. Research has found that older adults who have a broad array of “weak” as well as “close” ties enjoy better physical and psychological well-being and live longer than people with less diverse social networks.
Brexanolone is a promising new treatment for postpartum depression. But one insurer’s requirement that women try four other drugs and electroconvulsive therapy before the infusion means it is out-of-reach for millions of women.
Missouri is the last state to create a monitoring program to help spot the misuse of prescription drugs. But some public health experts warn that the nation’s programs are forcing people addicted to opioids to seek deadlier street options.
With covid cases on the upswing again around the country, partisan division remains over how to address the pandemic. Meanwhile, the Biden administration proposes bigger penalties for hospitals that fail to make their prices public as required. Stephanie Armour of The Wall Street Journal, Alice Miranda Ollstein of Politico and Tami Luhby of CNN join KHN’s Julie Rovner to discuss these issues and more. Also, for “extra credit,” the panelists suggest their favorite stories of the week they think you should read, too.
Black women and girls with attention deficit hyperactivity disorder often remain undiagnosed because their symptoms are mischaracterized by the blinders of sexism and racism. Getting treatment and finding the right medication can be even more difficult because they aren’t taken seriously or, worse, they’re racially profiled while getting their medicines.
Two intractable failings of the U.S. health care system — addiction treatment and medical costs — come to a head in the ER, where patients desperate for addiction treatment arrive, only to find the facility may not be equipped to deal with substance use or, if they are, treatment is prohibitively expensive.
It could take years for follow-up studies to prove Aduhelm slows the disease — or doesn’t. Meanwhile, its maker will profit.
The potential benefits of Aduhelm are small, its effectiveness is not certain, and even the FDA Thursday shifted its guidance on who should get the drug. But physicians are dealing with an onslaught of interest from patients and their families, and figuring out which patients are best positioned to be helped by the drug will be difficult.
The state will be the first to offer comprehensive counseling services to parents during pediatric visits as part of Medicaid.
Long before covid, music therapists used singing and wind instruments to help COPD and asthma patients. These same therapies might help patients recover from covid’s lingering symptoms as well. And though it wasn’t clinical music therapy, singing with an online choir has helped me navigate long covid.